Suche

Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit

4.6 (790) · € 35.50 · Auf Lager

Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit
Neulasta® (pegfilgrastim) Onpro® kit

Neulasta® (pegfilgrastim) Onpro® kit

Wearable injectors news and trends

Wearable injectors news and trends

Pegfilgrastim Biosimilar Market Size, Demand & Growth Report

Pegfilgrastim Biosimilar Market Size, Demand & Growth Report

Amgen 2018: Company-wide transformation - PharmaLive

Amgen 2018: Company-wide transformation - PharmaLive

Access & Resources  Neulasta® (pegfilgrastim) Onpro®

Access & Resources Neulasta® (pegfilgrastim) Onpro®

Neulasta® (pegfilgrastim) Onpro® kit

Neulasta® (pegfilgrastim) Onpro® kit

Coherus Announces Positive Final Overall Survival Results of JUPITER-02  Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma -   MedNews

Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma - MedNews

WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS - ONdrugDelivery

WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS - ONdrugDelivery

How Risky Was Amgen's Onpro Advertising?

How Risky Was Amgen's Onpro Advertising?

Biosimilars 2021 Year in Review

Biosimilars 2021 Year in Review

Coherus' newly minted Neulasta biosim steps up pressure on Amgen

Coherus' newly minted Neulasta biosim steps up pressure on Amgen

Humira, Radio Compass Blog, Latest Pharmaceutical Articles

Humira, Radio Compass Blog, Latest Pharmaceutical Articles